1 week Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade Zacks

Enanta Pharmaceuticals (ENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.